Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers-Reference-Cited by-同舟云学术

Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers

Published:2011-02-18 Issue:6 Volume:51 Page:1228-1240
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Jilma-Stohlawetz Petra,Kursten Friedrich W.,Walasek Claudia,Horvath Michaela,Leitner Gerda,List Jana,Quehenberger Peter,Schwameis Michael,Bartko Johann,Jilma Bernd

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2010.03005.x/fullpdf

Reference27 articles.

1. Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction;McManigal;Am J Clin Pathol,1999

2. Lesson of the week: incompatible plasma transfusions and haemolysis in children;Duguid;BMJ,1999

3. The Norwegian Plasma Fractionation Project-a 12 year clinical and economic success story;Flesland;Transfus Apher Sci,2003

4. 2010 Blood types in the U.S. http://bloodcenter.stanford.edu/about_blood/blood_types.html

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures;Cochrane Database of Systematic Reviews;2019-11-28

2. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures;COCHRANE DB SYST REV;2019

3. Study on the immunological safety of universal plasma in the Chinese population in vitro;Transfusion and Apheresis Science;2017-04

4. Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use;BLOOD TRANSFUS-ITALY;2016

5. Hemostatic Efficacy of Pathogen-Inactivated Blood Components;Seminars in Thrombosis and Hemostasis;2015-12-30